Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Single Center Off-Label Benralizumab use for Refractory Hypereosinophilic Syndrome Demonstrates Satisfactory Safety and Efficacy”.
Anna M. Aalbers, Maud A.W. Hermans, Yvonne Veltman, Pim Mutsaers